Literature DB >> 23279863

Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.

Buxi Shi1, Rihui Cao, Wenxi Fan, Liang Guo, Qin Ma, Xuemei Chen, Guoxian Zhang, Liqin Qiu, Huacan Song.   

Abstract

A series of bivalent β-carbolines with a spacer of three to ten methylene units between the indole nitrogen was synthesized and evaluated as antitumor agents. The results demonstrated that compounds 18c, 21b, 25a and 31b exhibited strong cytotoxic activities with IC(50) value of lower than 20 μM against four tumor cell lines. Acute toxicities and antitumor efficacies of the selected compounds in mice were also evaluated, compounds 18b, 21b, 26a and 31b exhibited potent antitumor activities with tumor inhibition rate of over 40% in animal models. Preliminary structure-activity relationships analysis indicated that (1) the spacer length affected antitumor potencies, and four to six methylene units were more favorable; (2) the introduction of appropriate substituent into position-1 of β-carboline facilitated antitumor potencies.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279863     DOI: 10.1016/j.ejmech.2012.11.033

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  Cu-catalyzed mild and efficient oxidation of THβCs using air: application in practical total syntheses of perlolyrine and flazin.

Authors:  Bo Zheng; Tien Ha Trieu; Tian-Zhuo Meng; Xia Lu; Jing Dong; Qiang Zhang; Xiao-Xin Shi
Journal:  RSC Adv       Date:  2018-02-12       Impact factor: 4.036

2.  Design, synthesis and evaluation of N13-substituted evodiamine derivatives against human cancer cell lines.

Authors:  Senchuan Song; Zhiyong Chen; Shaoxue Li; Yanmin Huang; Yiqian Wan; Huacan Song
Journal:  Molecules       Date:  2013-12-17       Impact factor: 4.411

3.  Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors.

Authors:  Liang Guo; Qin Ma; Wei Chen; Wenxi Fan; Jie Zhang; Bin Dai
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

4.  Synthesis and In Vitro Antitumor Activity of Novel Bivalent β-Carboline-3-carboxylic Acid Derivatives with DNA as a Potential Target.

Authors:  Hongling Gu; Na Li; Jiangkun Dai; Yaxi Xi; Shijun Wang; Junru Wang
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

5.  Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents.

Authors:  Xiaofei Chen; Liang Guo; Qin Ma; Wei Chen; Wenxi Fan; Jie Zhang
Journal:  Molecules       Date:  2019-08-14       Impact factor: 4.411

6.  Anthranilamides with quinoline and β-carboline scaffolds: design, synthesis, and biological activity.

Authors:  Maja Beus; Leentje Persoons; Dirk Daelemans; Dominique Schols; Kirsi Savijoki; Pekka Varmanen; Jari Yli-Kauhaluoma; Kristina Pavić; Branka Zorc
Journal:  Mol Divers       Date:  2022-01-08       Impact factor: 3.364

Review 7.  β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.

Authors:  Jay Prakash Soni; Yogesh Yeole; Nagula Shankaraiah
Journal:  RSC Med Chem       Date:  2021-03-24

8.  A Small β-Carboline Derivative "B-9-3" Modulates TGF-β Signaling Pathway Causing Tumor Regression in Vivo.

Authors:  Hui Zhong; Abdelkader Daoud; Jichun Han; Xiaohong An; Caili Qiao; Lanlan Duan; Yichuan Wang; Zhenfeng Chen; Jia Zhou; Jing Shang
Journal:  Front Pharmacol       Date:  2018-07-19       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.